2024-02-09 07:20:01 ET
- Precision BioSciences ( NASDAQ: DTIL ) Friday announced that its Board of Directors has approved a 1-for-30 reverse stock split of the company’s common stock to increase the per-share market price to meet the minimum per share bid price requirement for continued listing on The Nasdaq Capital Market.
- The reverse stock split will become effective at 5:00 p.m. Eastern Time on February 13, 2024, after close of trading on The Nasdaq Capital Market.
- The company’s common stock is expected to commence trading on a split-adjusted basis when the markets open on February 14, 2024 under the existing trading symbol “DTIL.”
- DTIL -3.70% premarket to $0.385
- Source: Press Release
Read the full article on Seeking Alpha
For further details see:
Precision Biosciences to effect a reverse stock split